Agents targeting inflammation in heart failure

Author： Gullestad Lars   Kjekshus John   Damås Jan Kristian   Ueland Thor   Yndestad Arne   Aukrust Pål  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.5, 2005-05, pp. : 557-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting histone deacetylases for heart failure

By Bush Erik W   McKinsey Timothy A  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 767-784

Informa Healthcare

Access to resources Recommend Favorite

Calcium Sensitising Agents in Heart Failure

By Mathew L.   Katz S.D.  

Drugs & Aging, Vol. 12, Iss. 3, 1998-03 ,pp. : 191-204

Adis International

Access to resources Recommend Favorite

Effective Agents Targeting the Mitochondria and Apoptosis to Protect the Heart

By  

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1153-1166

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cardiomyocyte Ca2 Homeostasis in Heart Failure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 431-448

Bentham Science Publishers

Access to resources Recommend Favorite

-Blockade in Heart Failure: Selective Versus Nonselective Agents

By Metra M.   Nodari S.   Dei Cas L.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 3-14

Adis International

Access to resources Recommend Favorite